At the time of writing, Medifast Inc [MED] stock is trading at $21.82, up 3.31%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MED shares have gain 8.94% over the last week, with a monthly amount drifted -13.21%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Medifast Inc [NYSE: MED] stock has seen the most recent analyst activity on June 05, 2024, when DA Davidson downgraded its rating to a Underperform and also revised its price target to $17.50 from $25. Previously, Stephens started tracking the stock with Equal-Weight rating on October 13, 2023, and set its price target to $82. On November 04, 2022, downgrade downgraded it’s rating to Neutral and revised its price target to $106 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $150 on August 04, 2022. Jefferies upgraded its rating to a Buy and raised its price target to $265 on January 25, 2021. DA Davidson upgraded its rating to Buy for this stock on November 05, 2020, and upped its price target to $205. In a note dated June 25, 2020, B. Riley FBR initiated an Buy rating and provided a target price of $164 on this stock.
For the past year, the stock price of Medifast Inc fluctuated between $18.81 and $109.52. Currently, Wall Street analysts expect the stock to reach $83.75 within the next 12 months. Medifast Inc [NYSE: MED] shares were valued at $21.82 at the most recent close of the market. An investor can expect a potential return of 283.82% based on the average MED price forecast.
Analyzing the MED fundamentals
According to Medifast Inc [NYSE:MED], the company’s sales were 897.81M for trailing twelve months, which represents an -49.93% plunge. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.1%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.22, Equity is 0.34 and Total Capital is 0.36. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.04 points at the first support level, and at 20.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.28, and for the 2nd resistance point, it is at 22.74.
Ratios To Look Out For
It is important to note that Medifast Inc [NYSE:MED] has a current ratio of 2.84. Further, the Quick Ratio stands at 2.25, while the Cash Ratio is 1.26. Considering the valuation of this stock, the price to sales ratio is 0.27, the price to book ratio is 1.13 and price to earnings (TTM) ratio is 3.52.
Transactions by insiders
Recent insider trading involved SCHLACKMAN SCOTT, Director, that happened on Mar 08 ’24 when 4053.0 shares were sold. Director, BROWN JEFFREY J completed a deal on Nov 07 ’23 to buy 58.0 shares. Meanwhile, Director SCHLACKMAN SCOTT bought 53.0 shares on Nov 07 ’23.
